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After 2.5 months of persistent infection in human neuroblastoma cells by the type 3 poliovirus (PV3) wild-type Leon strain,
a mutant (PVpi), L2-2, capable of establishing a persistent infection in nonneural HEp-2c cells was isolated. Sequence
analysis of the viral capsid protein genes revealed the presence of seven missense mutations, three of which were also
present in a second PVpi, suggesting that they could be important determinants of the persistent phenotype. When the three
mutations were introduced into the lytic Leon strain separately, in pairs or all together, all but one of the viruses was capable
of establishing a persistent infection. However, aside from the triple mutant, only one mutant virus, bearing a Leu at position
VP213 in the capsid interior and an Asn at position VP1290 on the capsid surface, was capable of establishing persistent
infections in more than 30% of the cultures. When present together, these two determinants affect the early steps of the virus
cycle including cell binding and the receptor-mediated conformational changes believed to be necessary for viral penetration
and uncoating. In fact, this persistent double mutant appears to undergo a novel capsid transition when in contact with the
human PV receptor, altering from the native virion which sediments at 160S to a form which sediments at about 147S. We
propose that this modification could be the mechanism by which PV3 is able to establish persistent infections in HEp-2c cell
cultures. © 1998 Academic Press
INTRODUCTION
As our understanding of viral disease increases, it is
becoming evident that many RNA viruses are able to
persist in their host after the primary infection. In order
to study the virus–cell interactions which are critical
for persistence, various in vivo and in vitro models
have been developed. In vivo, the study of persistent
infection is complicated by the presence of the im-
mune system. In vitro models are much simpler and
have facilitated the study of both the cellular and the
viral components of persistent infection for many vi-
ruses, including the pathological agent of paralytic
poliomyelitis, poliovirus (PV).
Although at the molecular level many cellular factors
have been implicated in the mechanisms of persistent
infection, the role played by the virus has also proved to
be essential. Indeed, in vivo studies with lymphocytic
choriomeningitis virus have shown that a single amino
acid change in the envelope glycoprotein is necessary
but not sufficient to confer the persistent phenotype to
the virus in vivo (Salvato et al., 1991). Similarily, for Thei-
ler’s virus a single amino acid substitution in the viral
capsid has been shown to be important for the persis-
tence of a chimeric virus (Jarousse et al., 1996).
While in vitro several members of the picornavirus
family other than PV are able to establish persistent
infections (de la Torre et al., 1985; Gercel et al., 1985;
Gratsch and Righthand, 1994; Matteucci et al., 1985;
Vallbracht et al., 1984), the identification of the precise
viral determinants involved in the capacity to efficiently
and consistently establish a persistent infection has
been hampered by the lack of persistent mutants which
differ from their parental lytic strain (or vice versa) by only
a few point mutations. We have developed in vitro mod-
els of persistent PV infection which overcome these
drawbacks and favor the study of the role of precise
point mutations in the genetic background of a parental
lytic strain (Borzakian et al., 1993; Calvez et al., 1993).
This model takes advantage of the simplicity of PV: a
small single-stranded positive-sense RNA enclosed in
an icosahedral capsid composed of 60 copies of each of
the four viral structural proteins (VP1, VP2, VP3, VP4). PV
is the most studied member of the picornavirus family,
and its genetic manipulation is facilitated by the exis-
tence of full-length infectious cDNA corresponding to
both the wild-type and the attenuated vaccine strains of
each of the three serotypes (Omata et al., 1984; Ra-
caniello and Baltimore, 1981; Ren et al., 1991; Stanway et
al., 1984).
Previous studies in our laboratory have shown that the
persistent infection of human neuroblastoma IMR-32
cells with both attenuated and wild-type strains of PV
selects for mutant viruses (PVpi) with phenotypic char-
acteristics that differ significantly from those of their
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parental viruses (Colbe`re-Garapin et al., 1989; Pelletier et
al., 1991). In particular, PVpi exhibit a modified cell tro-
pism; they are able to readily establish persistent infec-
tions in the human nonneural cell line HEp-2c, in contrast
to the parental PV which are lytic in these cells. The
mechanisms of establishment of a persistent infection in
HEp-2c cell cultures differ from that of the maintenance
(Borzakian et al., 1992). While a modified cell phenotype
due to cell selection is most probably responsible for this
latter phase, the characteristics of the virus are crucial
during the establishment phase, i.e. during the first few
weeks of infection.
Initial studies with a type 1 PVpi showed that the
mutations sufficient to confer the persistent phenotype
in HEp-2c cells to the normally lytic Sabin 1 strain
were scattered throughout the VP2, VP3, VP1, and 2A
genes (Calvez et al., 1993). Considering the possibility
that the determinants of persistence in HEp-2c cells
may differ between the three serotypes, as was ob-
served in the case of neurovirulence, it was decided to
isolate and analyze a second PVpi of a different sero-
type. In our laboratory, persistent infections have al-
ready been easily established with both the attenu-
ated Sabin 3 and the wild-type Leon strains of type 3
PV (PV3) in IMR-32 cells (Colbe`re-Garapin et al., 1989).
Furthermore, type 3 PVpi derived from the Leon strain,
capable of establishing persistent infections in HEp-2c
cells could be isolated much earlier from infected
neuroblastoma cells than in the case of type 1 PVpi
(our unpublished data), leading us to suppose that
type 3 PVpi genomes would contain fewer mutations
than type 1 PVpi.
In this study, a type 3 PVpi, selected during persis-
tent infection of IMR-32 cells by the wild-type Leon
strain, was used to efficiently establish persistent in-
fections in HEp-2c cell cultures while the wild-type
Leon strain, which under our conditions never gave a
single colony of persistently infected cells, was used
as a negative control. The construction of point mutant
viruses led to the identification of two viral determi-
nants which act cooperatively to allow PV3 to estab-
lish persistent infections in HEp-2c cell cultures. Their
respective locations, one on the surface and one on
the inside of the capsid, suggested that they could
possibly be involved in PV–receptor interactions and
capsid stability. We therefore focused the second part
of this study on the elucidation of the mechanisms
underlying the establishment of PV3 persistence in
HEp-2c cell cultures.
RESULTS
Identification of the genomic region involved in PV3
persistence
A type 3 PVpi, L2-2, was isolated and cloned after 2.5
months of persistent infection of neuroblastoma IMR-32
cells by Leon-lab. This virus readily established persis-
tent infections in HEp-2c cells. In fact, in 100% of the
infections by L2-2, a subconfluent cell monolayer re-
mained intact underneath a second layer of dead cells
during the first few weeks of infection. Later in infection,
portions of the cell monolayer were lysed, but 30–50% of
the cells survived, even in the presence of actively rep-
licating virus. As the lytic viruses T7-Leon and Leon-lab
were never able to establish persistent infections when
inoculated under the same conditions as L2-2, persis-
tence could not be explained by cell selection alone. The
viral determinants of L2-2 involved in this phenotype
were therefore investigated.
Based on our previous results with a type 1 PVpi
(Calvez et al., 1993), a region of the viral RNA corre-
sponding to part of the 59 noncoding (NC) region, the
entire capsid protein-encoding region and the nonstruc-
tural protein 2A, from nucleotide (nt) 455 to nt 3932, was
sequenced for L2-2 and its parental Leon-lab strain. In
order to verify that the sequence of our Leon-lab strain
was in agreement with the published PV3 sequence
(Stanway et al., 1984), the two genomes were compared
in this region. Sequence comparison revealed the pres-
ence of five differences: two mutations in the 59NC re-
gion (nt 486 A3 G and 653 U3 C) and three mutations
at nt 2903, 3197, and 3335 in VP1 (modifying amino acids
Ala143 3 Thr, Val241 3 Ile, Asn287 3 Asp), which were
also present, as would be expected, in the genome of
L2-2 (Fig. 1). These differences are not surprising con-
sidering the quasi-species nature of RNA viruses (Do-
mingo et al., 1985). Comparison of the sequences of the
L2-2 and Leon genomes revealed the presence of seven
additional missense mutations and three silent muta-
tions in the P1 capsid protein-encoding region (Table 1).
The missense mutations were scattered throughout the
VP4, VP2, VP3, and VP1 genes, while the silent mutations
were found only in the VP4 and VP3 genes. No mutations
were found in the 2A gene of L2-2, indicating that this
nonstructural protein is not involved in the persistence of
this PVpi in HEp-2c cells.
To confirm that the mutations responsible for the
persistent phenotype were localized in the capsid pro-
tein-encoding region of the genome, a recombinant
T7-Leon bearing the P1 region of L2-2, named T7L/
P1(L2-2), was constructed. After transfection, the viral
RNA was sequenced in the amplified region (from nt
477 to nt 3813), and two additional mutations, one
missense in VP4 modifying amino acid Thr293 Ala (nt
827 A3 G) and one in the 59NC region (nt 628 A3 G),
were found. DNA sequencing confirmed that they were
both present in the RT-PCR amplified fragment, possi-
bly due to the quasi-species nature of L2-2. The con-
struction of subsequent persistent viruses which did
not contain these two mutations (as shown in Fig. 1)
clearly eliminated the possibility that they play a role
in viral persistence. The virus T7L/P1(L2-2) was capa-
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ble of readily establishing a persistent infection in
HEp-2c cells which closely resembled that observed
for L2-2, in that cytopathic effects were scarcely visible
in the cell monolayer. Thus, the mutations present in
the P1 region of the L2-2 genome were sufficient to
confer the persistent phenotype to a lytic PV3.
FIG. 1. Genomic maps of the fragment NcoI (nt 477–3813) of the parental viruses PV Leon and PVpi L2-2 and of the mutant viruses constructed by
either recombination (T7L/P1(L2-2) and T7L/P1(L2-2/T7L)) or site-directed mutagenesis and recombination (T7L12L131R1661N290 and related viruses).
The full-length PV genome (7431 nt) including the 59 noncoding region (59NC), the viral genes, and the 39 noncoding region (39NC) is shown
schematically. Nucleotides in our laboratory strain (Leon-lab) which differ from those published for the Leon strain (T7-Leon) are indicated by vertical
arrows. Mutations found in the P1 region of PVpi L2-2 are indicated as follows: short arrowheads, silent mutations; long arrowheads, missense
mutations. Missense mutations also present in the genome of a second PVpi, S31, are indicated by long black arrowheads, and the two additional
mutations present in the cDNA corresponding to viruses T7L/P1(L2-2) and T7L/P1(L2-2/T7L) are illustrated by dotted arrows. The viral phenotype in
HEp-2c cells as deduced from the percentage of persistently infected cell cultures is indicated on the right-hand side. We considered viruses which
established persistent infections in greater than 15% of infected cultures to be persistent, while those which persisted in 1 to 14% of the infections
to be poorly persisting, and those that never persisted to be lytic.
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Precise mutations responsible for PV3 persistence
To determine the mutations responsible for the persis-
tent phenotype, the positions corresponding to the mu-
tations present in the genome of the PVpi L2-2 were
checked by direct sequencing of the genomic RNA of
another PVpi, S31, which had been previously isolated
after 6 months of persistent infection of IMR-32 cells by
the attenuated Sabin 3 strain (Pelletier et al., 1991). None
of the silent mutations present in the P1 region of the
L2-2 genome were found to be present in the S31 ge-
nome. However, three missense mutations (nt 986, 2973,
and 3344) were found to be common to the two viruses
(Table 1). In order to see if these mutations were respon-
sible for the capacity of the PVpi L2-2 to efficiently es-
tablish persistent infections in HEp-2c cell cultures, they
were introduced into pT7-Leon either together, in pairs,
or separately.
All of the mutant viruses were used to infect HEp-2c
cell cultures in order to determine their phenotype of
persistence in these cells, expressed as the percentage
of cultures in which a persistent infection was observed
between 5 and 8 weeks postinfection (Table 2). All vi-
TABLE 1
Nucleotide and Amino Acid Differences between the Lytic (PV) and Persistent (PVpi) Strains of PV Type 3 in the P1 Region
Genome
region
Nucleotide Amino Acid
Position PV Leon PVpi L2-2 PVpi S31a Position PV Leon PVpi L2-2 PVpi S31
VP4 766 A G A — — — —
880 C U C — — — —
928 A G A 62 Ile Met Ile
VP2 986 G U U 13 Val Leu Leu
VP3 1916 A U A 52 Met Leu Met
2248 A G A — — — —
VP1 2582 U A U 36 Ser Thr Ser
2747 G A G 91 Asp Asn Asp
2973 A G G 166 Lys Arg Arg
3344 G A A 290 Asp Asn Asn
a Only the positions corresponding to the mutations and amino acid substitutions present in the genome of the PVpi L2-2 were sequenced in the
genome of the PVpi S31. Positions, mutations, and amino acid substitutions common to both PVpi are underlined.
TABLE 2
Phenotypic Differences between the Lytic PV3 Leon Strain and the Mutant Viruses
Virus
Percentage of persistently infected
HEp-2c cell culturesa
Average difference in titer
on IMR-32 and HEp-2c cellsb
Average plaque diameter
on HEp-2c cellsc
T7-Leond 0 20.8 4.6
L2-2 100 1.0 1.1
T7L/P1(L2-2) 100 1.7 0.8
T7L/P1(L2-2/T7L) 92 nde nd
T7L12L131R1661N290 69 0.7 1.6
T7L12L131R166 7 0.4 2.4
T7L12L131N290 32 0.4 2.1
T7L11R1661N290 10 20.1 2.8
T7L12L13 1 20.4 3.6
T7L11R166 0 20.3 3.5
T7L11N290 4 20.5 4.0
a Expressed as the percentage of infected cell cultures with growing cell colonies 5 to 8 weeks postinfection. A minimum of five separate
experiments was performed with each virus, for a total of at least 44 infected cultures per virus.
b Titers were determined by an end point micromethod and the difference is expressed as log10 ID50/ml. The average of a minimum of three
independent experiments is presented.
c Virus-infected monolayers were stained after 4 days of incubation at 37°C under a 0.8% agarose overlay. Each result is the average of $40 plaque
measurements (in mm) from a minimum of three independent experiments.
d The virus T7-Leon was obtained by transfection of IMR-32 cells by the plasmid pT7-Leon. Although identical results were obtained with the
laboratory strain of Leon (Leon-lab), the virus T7-Leon was chosen for all of the experiments as it is derived from the plasmid that was used to
construct the mutant viruses.
e nd, not determined.
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ruses capable of establishing a persistent infection in
less than 15% of the cultures (Table 2), under our exper-
imental conditions, were considered to be poorly persist-
ing, while those capable of efficiently establishing a
persistent infection in a greater percentage of cultures
were considered to be persistent. Accordingly, we con-
sider L2-2, T7L/P1(L2-2), T7L/P1(L2-2/T7L), T7L12L131R166
1N290,and T7L12L131N290 to be persistent viruses in our
HEp-2c cell model.
While the persistent infections established with the
recombinant virus T7L/P1(L2-2/T7L) developed in much
the same manner as was observed for L2-2 and T7L/
P1(L2-2), infections with the mutant viruses containing
one, two, or three point mutations progressed quite dif-
ferently. Indeed, the cell monolayer was almost com-
pletely destroyed by cell lysis during the first week, and
only a very small number of the cells infected did survive
infection. Then, between 5 and 8 weeks postinfection,
growing cell colonies appeared in cultures infected with
all viruses except the negative control T7-Leon and
T7L11R166. Further, in the case of the triple mutant
T7L12L131R1661N290, and all of the double mutants
(T7L12L131R166, T7L12L131N290, and T7L11R1661N290),
cells easily survived when the colonies were subcultured
after at least 8 weeks, despite virus production, indicat-
ing that the persistent infection was well established. It
is important to note that the trypsinization procedure
totally dissociates cells thereby exposing all susceptible
cells to the virus, and it is therefore highly unlikely that
uninfected HEp-2c cells could have escaped infection.
The essential role of the viral determinants in the
establishment of these persistent infections was further
revealed by the cumulative effect observed in function
of the number of mutations present in the mutant
genomes. Indeed, the mutant T7L/P1(L2-2) persisted in
100% of the cultures while T7L/P1(L2-2/T7L) and
T7L12L131R1661N290 persisted in only 92 and 69% of the
cultures, respectively (Table 2). The correlation between
the number of mutations and the ability to persistently
infect HEp-2c cell cultures was further confirmed by
studying the point mutants. Indeed, a greater number of
living cells was seen in a greater percentage of the
cultures infected with the triple mutant T7L12L131R166
1N290 than with the double mutants (T7L12L13
1R166, T7L12L131N290, and T7L11R1661N290), which in turn
established persistent infections more frequently than the
single mutants T7L12L13 and T7L11N290 (Table 2).
Prior to infection, the absence of undesired mutations
in the genome of the efficiently persisting virus
T7L12L131N290 had been confirmed by sequencing the
viral RNA corresponding to the entire P1 capsid-encod-
ing region. Therefore, the persistent phenotype of this
double mutant suggested that a precise pair of missense
mutations was sufficient to confer the ability to persist to
the otherwise lytic PV3 Leon strain. After 7 and 11 weeks
of infection by T7L12L131N290, extracellular medium was
sampled and used to infect HEp-2c cells under exactly
the same conditions as were used to test the mutant
viruses. These supernatants proved to be less persistent
than the initial inoculated virus (data not shown), sug-
gesting that selection of viruses increasingly lytic for
these cells had occurred in persistently infected cul-
tures. Although these mutations, which probably
emerged due to the high mutation rate of RNA viruses
(Domingo et al., 1985), are clearly not advantageous for
the establishment of persistence, their eventual role dur-
ing the maintenance phase cannot be excluded. The
presence of the introduced mutations was confirmed in
the virus after more than 8 weeks of persistent infection,
indicating that they had not reverted.
Modified cell tropism of the mutant viruses
Previously in our laboratory, while working with PVpi
derived from IMR-32 cells persistently infected by all
three Sabin strains, we developed two kinds of criteria in
order to further characterize the cell tropism of our mu-
tant viruses: the difference in infectious titer on IMR-32
cells versus titer on non-neural HEp-2c cells, and the
size of plaques on HEp2c cells. In fact, PVpi had signif-
icantly lower titers and made smaller plaques on HEp-2c
cells (Colbe`re-Garapin et al., 1989; Pelletier et al., 1991).
To further study the mutant PV3 Leon viruses, these
same phenotypic markers were tested for the viruses
illustrated in Fig. 1.
The difference in titer on IMR-32 versus HEp-2c cells
(Table 2) was negative for the lytic viruses T7-Leon and
T7L11R166 and for the poorly persisting viruses
T7L11R1661N290, T7L12L13, and T7L11N290, indicating
that they were better adapted to HEp-2c cells than to
IMR-32 cells. In contrast, the difference in titer on IMR-32
versus HEp-2c cells varied between 0.4 and 1.7 log10
ID50/ml for viruses capable of persistently infecting
greater than 15% of HEp-2c cell cultures (Table 2), re-
vealing that a good correlation exists between the mod-
ified cell tropism and the ability to establish persistent
infections for all of the viruses except T7L12L13
1R166. This was further confirmed by the observation that
plaques produced by persistent viruses were two- to
sixfold smaller than those produced by the lytic control
virus, T7-Leon (Table 2). As the greatest differences in
comparison to T7-Leon are seen with the mutant T7L/
P1(L2-2), there is most certainly a cumulative effect of
many mutations playing a role in cell tropism.
In order to facilitate the elucidation of the mecha-
nisms of persistence in HEp-2c cells we chose to
focus on the persistent mutant T7L12L131N290 which
carries only two mutations. The two point mutants
T7L12L13 and T7L11N290, which bear each of these
mutations independently, the persistent mutant T7L/
P1(L2-2) and the lytic T7-Leon strain were all used as
controls.
18 DUNCAN, PELLETIER, AND COLBE`RE-GARAPIN
Analysis of the postentry steps of the virus cycle
It is most probable that amino acid substitutions
present in the viral capsid play a role either during the
early steps of the viral cycle, i.e., receptor binding and
the associated conformational changes which are nec-
essary for penetration and uncoating, or much later,
during capsid assembly. Therefore, to distinguish be-
tween these two possibilities, we investigated whether
or not the postentry steps of the virus cycle were modi-
fied in the case of the persistent viruses. In order to do
so, HEp-2c cells were transfected with PV RNA, and the
intracellular and extracellular virus productions were
measured. When the early steps of the virus cycle were
by-passed by transfection of viral RNA, both the double
mutant T7L12L131N290 and the two corresponding single
mutants were produced intracellularly and liberated in
the extracellular medium at a level comparable to that of
the lytic virus T7-Leon (Fig. 2A). These results suggest
that the modified phenotype of the persistent virus
T7L12L131N290 is most likely due to alterations in the
virus–receptor interactions which occur early in the virus
cycle. In contrast, in the case of the persistent mutant
T7L/P1(L2-2) which carries all seven of the missense
mutations present in the capsid of L2-2, it is interesting to
note that although the liberation of mature virions does
not appear to be affected, the intracellular virus produc-
tion is greatly decreased (Fig. 2A). This virus is therefore
impaired at one or several of the postentry steps.
In agreement with these results, single-step growth
experiments indicate that although the growth of the
persistent double mutant, T7L12L131N290, is delayed in
the first few hours postinfection, probably due to defects
during the early steps of the viral cycle, this virus is
produced at a level comparable to that of T7-Leon after
24 h of infection (Fig. 2B).
Two modified residues involved in increased
receptor-binding
In light of the results obtained in the growth curve
experiments (Fig. 2), the early steps of the virus cycle
were analyzed for the same five viruses, starting with the
adsorption of the virus onto HEp-2c cells at 0°C. The
persistent double mutant T7L12L131N290 bound to
HEp-2c cells much more readily than either the lytic
T7-Leon or the persistent T7L/P1(L2-2) strain (Fig. 3A). As
early as 30 min postinfection there was over twice as
much T7L12L131N290 bound as T7-Leon. The two point
mutants had intermediate binding profiles, suggesting a
cumulative effect of the two mutations, although at the
later time points it appears that there was as great a
percentage of T7L12L13 bound as that of T7L12L13
1N290. The fact that the highly persistent mutant T7L/
P1(L2-2) bound even more poorly than the wild-type
T7-Leon strain probably reflects the conflicting effects of
a much greater number of mutations.
Decreased particle elution at 37°C for persistent
mutants
It is generally accepted that PV penetration and un-
coating pass by way of an intermediate particle (Flore et
al., 1990; Fricks and Hogle, 1990) which is generated by
virus–receptor interactions (Gomez Yafal et al., 1993;
Kaplan et al., 1990), although recent evidence has sug-
gested that this particle may not be indispensible for
infection (Dove and Racaniello, 1997; Kronenberger et al.,
1994). Further, it has been observed that at physiological
temperature this altered particle, which sediments at
135S (De Sena and Mandel, 1977; Fenwick and Cooper,
1962; Lonberg-Holm et al., 1975), is both internalized
(Everaert et al., 1989; Lonberg-Holm et al., 1975) and
released into the extracellular medium, a process known
as elution (Joklik and Darnell, 1961). As increased elution
could mean that less viral RNA would reach the cyto-
plasm, it was hypothesized that this could be a mecha-
nism of persistence for the mutant viruses. Therefore, the
quantity of cell-associated virus particles corresponding
to T7-Leon and each of the four mutant viruses was
measured at various time points after incubation at 37°C
(Fig. 3B). It is evident that all of the mutant viruses, i.e.,
the persistent T7L/P1(L2-2) and T7L12L131N290 strains
and even the poorly persisting T7L12L13 and
T7L11N290 strains, elute much less than the wild-type
T7-Leon strain. These results confirm that the two mod-
ified residues VP213 and VP1290 are both capable of
altering virus–receptor interactions, even when intro-
duced independently.
Analysis of the receptor-induced conformational
changes in the viral capsid
As the altered binding and elution profiles suggested
that the initial virus–receptor interactions were affected,
the uncoating transitions were analyzed in order to better
understand the mechanism(s) underlying the modified
viral phenotype. For this we chose to focus on the per-
sistent virus T7L12L131N290, while the wild-type T7-Leon
strain was maintained as the lytic control virus.
We first studied the kinetics of the receptor-induced
conformational changes in the viral capsid, i.e., the rate
of transition from the 160S particle to the 135S particle.
For these experiments, infection was synchronized by
2.5 h of adsorption at 0°C, and then conformational
transitions were initiated by incubation for various times
at 37°C. The lytic virus T7-Leon had a classic uncoating
profile (Fig. 4, top), with one peak corresponding to the
160S virions present after both 0 and 30 min of incuba-
tion at 37°C and a second peak corresponding to the
135S particles present only after incubation at 37°C. In
contrast, the profile observed for the persistent mutant
T7L12L131N290 was highly atypical (Fig. 4, bottom). In
fact, at 0 min postadsorption there was neither a peak
corresponding to the 160S virions nor to the 135S parti-
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cles, but rather a very wide peak found at an intermedi-
ate position between the fractions normally containing
these two peaks. This peak was seen to increase in size
in function of the time of incubation at 37°C, but the
coefficient of sedimentation did not appear to change, as
the peak remained at its intermediate position even
when infected cells were incubated for up to 90 min at
37°C (data not shown). The sedimentation coefficient
corresponding to this novel peak was estimated to be
147 6 3S as described under Materials and Methods.
As this 147S form accumulated during the 2.5 h of
adsorption on ice, the kinetics of the transformation of
T7L12L131N290 at 0°C were analyzed and compared to
those of T7-Leon at the same temperature (Fig. 5A, left).
For the lytic virus T7-Leon, the 160S virions were present,
as could be expected. Remarkably, however, in the case
of the persistent mutant T7L12L131N290, we observed
that at 0°C the transition of the virion to this new form
occurred as early as 15 min postinfection, with the peak
increasing in function of the incubation time on ice. No
160S virions were visible, suggesting that they were
either masked by the wide peak corresponding to the
147S form or that all of the cell-associated viral particles
FIG. 4. PV receptor-induced particle alteration for the lytic virus
T7-Leon and the persistent double mutant T7L12L131N290 in HEp-2c
cells. Cells were incubated with [35S]methionine-labeled viruses for
2.5 h at 0°C in order to synchronize the infection. Cells were then either
washed and lysed (T 5 0 min) or transferred to 37°C (T 5 30 min) to
permit receptor-induced conformational transitions. After 30 min of
agitation at this temperature cells were washed and lysed. Cell lysates
were then separated by sucrose gradient (15–30%) centrifugation as
described under Materials and Methods. Purified 160S and 80S parti-
cles were used as markers in parallel gradients.
FIG. 3. Analysis of virus adsorption and particle elution in HEp-2c
cells for the lytic parental T7-Leon strain, the persistent T7L/P1(L2-2)
and T7L12L131N290 strains, and the two corresponding point
mutants T7L12L13 and T7L11N290. (A) Kinetics of virus–receptor
binding at 0°C. HEp-2c cells in suspension were infected with
[35S]methionine-labeled viruses and agitated on ice for the times
shown. The cell-associated radioactivity was counted and ex-
pressed as a percentage of the radioactivity present in the inocu-
lum. (B) The elution rates of attached particles at 37°C. HEp-2c cells
in suspension were infected with [35S]methionine-labeled viruses
and the virus was allowed to adsorb for 2.5 h at 0°C. Infected cells
were then washed twice and agitated at 37°C for the indicated
times. The cell-associated radioactivity was counted and expressed
as a percentage of the radioactivity present prior to the 37°C
incubation period. For both the adsorption and the elution experi-
ments, the average of three independent experiments is presented,
and the vertical error bars represent the standard errors of the
means.
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FIG. 5. PV receptor-induced particle alteration at 0 and 37°C for the lytic virus T7-Leon and the persistent double mutant T7L12L131N290 in HEp-2c cells. (A)
Kinetics of conformational changes at 0 and 37°C. Cells were incubated with [35S]methionine-labeled viruses for the indicated times either at 0°C or directly at 37°C.
Cells were then washed and lysed and the viral particles were separated by sucrose gradient (15–30%) centrifugation as described under Materials and Methods.
(B) Comparison of the PV receptor-altered particles present in the cell-associated and extracellular fractions of HEp-2c cell cultures incubated for 90 min either at
0°C or directly at 37°C. Cells were treated as described in (A) except that, before washing, one-quarter of the volume of the extracellular medium was sampled for
each infection. Both cells and extracellular supernatants were then lysed and analyzed as described above. In the case of the HEp-2c cells incubated with T7-Leon
at 37°C (B, top right), the results are shown for one-half of the volume of the extracellular supernatant. Purified 160S and 80S particles were used as markers in
parallel gradients.
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had already been transformed. In order to verify that the
virion was not in fact simply altered by the postinfection
treatment (lysis and ultracentrifugation in sucrose gradi-
ents), we checked for the presence of 160S virions in
the extracellular medium of the T7L12L131N290-in-
fected cells. In fact, the same peak corresponding to the
160S virions was present in the extracellular fractions for
both T7-Leon and T7L12L131N290, despite the postinfec-
tion treatment (Fig. 5B, left). This suggests that this 147S
form is not due to the fragility of the T7L12L131N290 cap-
sid, but rather to the fact that it undergoes novel confor-
mational transitions when in contact with the human PV
receptor present on HEp-2c cells. In order to verify that
this phenomenon was not due to nonspecific virus–
HEp-2c cell interactions, the same experiments were
repeated, incubating the virus for 90 min at 0°C with
murine L-M cells which do not express a functional PV
receptor (Fig. 6A). No cell-associated particles were re-
covered for either T7-Leon or T7L12L131N290, and the
virions present in the extracellular medium were in the
fractions corresponding to the 160S particles as was
observed in HEp-2c cells. To confirm that the 147S form
was indeed due to specific PV–receptor interactions, the
viruses were incubated 90 min on ice with murine L-M
cells expressing a functional human PVR receptor (L-M/
PVR1 cells). Both the cell-associated particles and the
extracellular particles (Fig. 6B, left) were found in the
same fractions as was seen with HEp-2c cells: in the
peak corresponding to the 160S particles for T7-Leon
and in the peaks corresponding to the 147S form and the
160S particles, respectively, for T7L12L131N290.
Taken together all of these results suggest that in the
case of the persistent virus T7L12L131N290 specific vi-
rus–receptor interactions are responsible for novel cap-
sid transitions which occur at 0°C. However, in our
persistent infection assays HEp-2c cells are infected by
adsorbing the viruses at 37°C; therefore, it was neces-
sary to confirm that the peak formation which occurs at
0°C also occurs in the same receptor-specific manner at
physiological temperature. For this purpose, we looked
at the transition kinetics of these two viruses directly at
37°C, without any prior adsorption at 0°C (Fig. 5A, right).
The profiles observed for T7-Leon were very similar to
the classic profiles seen in the preliminary experiments
where the virus was first adsorbed onto the cells on ice
and then shifted to 37°C (Fig. 4). After 45 min of direct
incubation at 37°C, three peaks were clearly visible: a
peak corresponding to the 160S particles, a peak corre-
sponding to the internalized 135S particles and a third
peak corresponding to the 80S empty capsids. All three
peaks increased in function of the duration of incubation
at 37°C, due to the fact that the infection had not been
synchronized by prior adsorption at 0°C. In contrast,
the profiles observed with the persistent mutant
T7L12L131N290 were once again atypical (Fig. 5A, bot-
tom right). Although the 80S empty capsids were visible
at both 45 and 90 min postinfection, neither the 160S
virions nor the 135S particles was detected. As was the
case at 0°C, it is possible that these forms were hidden
under the peak corresponding to the 147S form and/or
that all cell-associated virions were immediately trans-
formed by contact with the human PV receptor. At 37°C,
extracellular medium from both T7-Leon- and T7L12L13
1N290-infected cells contained the 160S virions (Fig. 5B,
right). Further, 135S particles were clearly visible in the
supernatant of the T7-Leon-infected cells, corres-
ponding to the elution of this particle. The 147S form was
not observed in the extracellular medium of the
T7L12L131N290-infected cells, suggesting that it does
not elute easily, an observation which is in agreement
with the elution profile observed for T7L12L131N290 (Fig.
3B). As was to be expected, when L-M/PVR1 cells were
incubated for 90 min with T7-Leon and T7L12L131N290 at
37°C (Fig. 6B, right) the profiles of the cell-associated
particles closely resembled those seen on HEp-2c cells
at this same temperature. These results confirm that
specific virus–receptor interactions are indeed responsi-
ble for the atypical conformational changes which occur
in the T7L12L131N290 capsid leading to the formation
of the 147S form, both at 37°C and, remarkably, even
at 0°C.
DISCUSSION
Two PV3 determinants important for the establishment
of persistence in HEp-2c cell cultures were identified by
a genetic approach, which focused on the mutations
found in the capsid-encoding region of a type 3 PVpi,
L2-2. The fact that this virus was isolated and cloned only
2.5 months postinfection in IMR-32 cells probably ex-
plains why only seven missense and three silent muta-
tions were found in the P1 region, as opposed to 19
mutations in the same region of a type 1 PVpi cloned
after 6 months of persistent infection (Calvez et al., 1993).
Site-directed mutagenesis allowed the construction of
viral mutants, most of which persisted at least to some
degree. Persistence was observed in 100% of the infec-
tions with T7L/P1(L2-2), probably due to the accumula-
tion of mutations in the genome, since a cooperative
effect was seen as the number of mutations increased.
However, despite the fact that the mutant T7L12L13
1N290 contained only two amino acid substitutions at
positions VP213 and VP1290, as confirmed by RNA se-
quencing, this virus was able to successfully establish
persistent infections in nearly one-third of HEp-2c cell
cultures. The fact that the negative control virus T7-Leon
was never able to persist under these same culture
conditions confirms that it is indeed the virus which plays
the crucial role in the establishment of persistent infec-
tion, even though cell selection undoubtedly does occur
during the first few weeks.
Although both mutations VP213 and VP1290 modified
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the difference in viral titers on IMR-32 versus HEp-2c
cells, as well as the size of plaques on HEp-2c cells
when studied independently, it appears that these two
determinants of cell tropism must be associated in order
to play an effective role in the establishment of PV3
persistence in HEp-2c cells, as when present separately
in the T7-Leon genome, persistent infections were never
established in more than 5% of the infected cultures.
It is probable that when together the two modified
amino acids contribute directly to the persistent pheno-
type in function of their location in the capsid. The first of
the two, at position VP213, is found in the N-terminal
region of VP2, at the interior of the viral capsid, in a
region believed to play a critical role in the capsid sta-
bility of the very closely related Sabin 3 strain (Filman et
al., 1989; Flore et al., 1990). In fact, this amino acid is
situated near the three-fold axis of symmetry, on the
border of a seven-stranded b sheet structure, composed
of four strands of VP3 and one strand of VP1 from one
protomer and two strands of VP2 from a neighboring
protomer, which is responsible for the stability between
pentameric subunits (Filman et al., 1989). The substitu-
tion of Val by the slightly bulkier amino acid Leu at
position VP213 could affect either the conformational
transitions which occur during receptor binding and viral
uncoating in HEp-2c cells or capsid assembly late in the
viral cycle, as the b sheet described above is an assem-
bly-dependent structure (Filman et al., 1989). The second
of the two modified residues present in T7L12L13
1N290, at position VP1290, is exposed at the surface of the
capsid in the carboxy-terminal region of VP1, in the neu-
tralization antigenic site 3a (Minor et al., 1986). This is
near the south rim of the canyon (Filman et al., 1989), but
outside of the putative footprint of the cellular receptor
(Colston and Racaniello, 1994; Olson et al., 1993). The
exact function(s) of amino acids located on the highly
accessible, hypervariable surface of the capsid are not
yet known, although it has been suggested that interac-
tions between the capsid and the PV receptor may in-
volve not only the canyon, but also the neutralization
antigenic sites lining the canyon (Harber et al., 1995). It is
therefore possible that the amino acid change at position
VP1290 could also modify capsid behavior during the
early steps of HEp-2c cell infection and, in particular,
receptor binding.
The increased affinity of the double mutant
T7L12L131N290 for the PV receptor is probably not in
itself a mechanism of persistence for this virus as the
two corresponding point mutants also have an increased
affinity, although they are only poorly persisting in our
HEp-2c cell model. Further, neither the increased ad-
sorption nor the decreased elution observed provides
likely explanations for the persistence of T7L12L13
1N290, as both of these phenomena increase the number
of viral particles present on the cell surface and thereby
increase the probability of infecting the cell. However, it
is evident that modified specific virus–receptor interac-
tions are responsible for an as of yet undescribed tran-
sition from the 160S virion to a 147S form in the case of
the persistent mutant T7L12L131N290. This new form
does not appear to be eluted as a 147S particle as it is
not found in the supernatant of infected cells after 1.5 h
of direct incubation at 37°C, even though about 35% of
the cell-associated radioactivity is found to be eluted at
this time (Fig. 3B). As no untransformed 160S virions
were found associated with the cells, even at early times,
it seems likely that the 160S 3 147S transition must
occur very rapidly, immediately upon contact with the
human PV receptor. It is remarkable to note that, while
135S particles are never generated when cells are incu-
bated with virus at less than 33°C (Gomez Yafal et al.,
1993), the 160S virion was transformed into the 147S form
even at 0°C. This suggests that the 160S 3 147S con-
formational transition requires very little energy as op-
posed to the 160S 3 135S transition. It is possible that
the 147S form is internalized and uncoated, as 80S empty
capsids are found in HEp-2c cells when infected at 37°C.
Alternatively, the 80S particles could be derived from
small amounts of 135S particles hidden under the 147S
peak.
When all of these observations are considered to-
gether, at least three different hypotheses could explain
how the modified virus–receptor interactions contribute
to persistence in HEp-2c cells. First, it has been pro-
posed by Dove and Racaniello (1997) that a second
particle, larger than the 135S particle and much less
stable, would be the true viral entry intermediate. It is
possible that the 147S form observed during infection
with T7L12L131N290 could be this intermediate. If this
were indeed so, the fact that the 147S form was visible
when cells were infected with T7L12L131N290 suggests
that in the case of this mutant virus, the 147S form must
be defective, thereby blocking or at least delaying the
penetration and uncoating steps. Such a mechanism
could certainly contribute to the establishment of a per-
sistent infection.
The fact that the 147S form was not found in the
supernatant, either at 0°C or at 37°C, suggests a second
hypothesis, i.e. that the 147S form of T7L12L13
1N290 would in fact be a nonfunctional or abortive un-
coating intermediate. However, as a normal viral yield is
observed when cells are infected at a high m.o.i. (Fig.
2B), such as was used for these transition experiments,
it seems highly unlikely that all of the visible cell-asso-
ciated virus would be in the supposed ‘‘abortive’’ 147S
form. It is much more probable that this 147S form would
be a poorly efficient alternative to the 135S particle,
preferentially induced by the receptor by way of an atyp-
ical capsid transition. Recent studies have suggested
that the 135S particle could create a pore in lipid mem-
branes and that this could allow for the release of the
viral RNA into the cytoplasm (Fricks and Hogle, 1990;
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Tosteson and Chow, 1997). If indeed the 135S particle is
a necessary uncoating intermediate (Curry et al., 1996), it
is possible that the 147S form described here performs
the same function but much less efficiently. The two
capsid substitutions which modify the behavior of
T7L12L131N290 during the specific PV–receptor interac-
tions preceding penetration and uncoating would there-
fore favor persistence by reducing the efficiency of RNA
release.
Finally, a third hypothesis is possible based on the
proposition made by Morrison et al. (1994). These au-
thors suggest that cytopathic effects occur as a conse-
quence of virus–receptor interactions. It is quite possible
that either the mutant virion T7L12L131N290 or the 147S
form could interact differently with the human PV recep-
tor expressed by HEp-2c cells. This could help to explain
how a virus could multiply without completely lysing the
entire host cell population.
In any case, although we cannot determine the precise
effects of the altered capsid transitions on the virus
cycle, and therefore which hypothesis is the most prob-
able, it appears evident that the modified virus–receptor
interactions play an important role in reducing the lytic
capacity of the virus, especially at the low m.o.i. used to
establish persistent infections in our HEp-2c cell model.
In conclusion, we report the identification of a precise
pair of viral determinants responsible for the capacity of
PV3 to efficiently and consistently establish a persistent
infection in HEp-2c cell cultures. We have further dem-
onstrated that these two substituted amino acids play an
important role in the early steps of the viral cycle by
altering virus–receptor interactions, and it is highly prob-
able that this contributes to the persistent phenotype. In
fact, the mutant virus T7L12L131N290 which carries the
two modified residues VP213 and VP1290, undergoes
novel conformational transitions upon contact with the
human PV receptor, resulting in the formation of an
intermediate form having a sedimentation coefficient of
about 147S. It will be interesting to better characterize
this form, as it may well be a useful tool to help us
improve our understanding of how PV persists in HEp-2c
cells and in particular how these viruses enter the cell
and release their genomic RNA into the cytoplasm.
MATERIALS AND METHODS
Cells and viruses
The human neuroblastoma cell line IMR-32, the hu-
man epithelial tumor cell line HEp-2c, and the murine
fibroblast cell line L-M(TK2) were cultivated in Dulbec-
co’s modified Eagle’s medium (DMEM) containing 10%
fetal calf serum (FCS), in the case of the IMR-32 cells, or
10% newborn calf serum (NCS), for the latter two cell
lines. The L-M/PVR1 cell line was made by cotransfect-
ing L-M(TK2) cells with the human PV receptor gene
(kindly provided by A. Nomoto, Tokyo, Japan (Koike et al.,
1990)) and a plasmid encoding for G418 resistance (Col-
be`re-Garapin et al., 1981). About 30% of these cells ex-
press the human PV receptor. Two strains of PV3 Leon
were used during this study. The first, our laboratory
strain Leon-lab, was acquired from the American Type
Culture Collection (ATCC). The second, T7-Leon, was
derived by transfection of IMR-32 cells with the plasmid
pT7-Leon (kindly provided by J. Almond, London, En-
gland). This plasmid carries a cDNA copy of a PV3 Leon
isolate obtained from the Centers for Disease Control
(Atlanta, GA) for which the sequence has been published
(Stanway et al., 1984). The PVpi L2-2 was isolated from
cell culture supernatant 2.5 months after the infection of
IMR-32 cells at a multiplicity of infection (m.o.i.) of about
100 infectious doses 50 (ID50) per cell by Leon-lab and
cloned by an endpoint micromethod. Briefly, 96-well
plates of neuroblastoma IMR-32 cells were infected with
10-fold dilutions of the cell supernatant. A first PVpi clone
was isolated from a well corresponding to the highest
virus dilution causing cytopathic effects and the proce-
dure was then repeated. The PVpi L2-2 was isolated from
this second round of cloning.
Construction of mutant viruses
In order to construct the recombinant virus T7L/P1(L2-
2), viral RNA corresponding to the L2-2 genome was
extracted from the cytoplasm of infected IMR-32 cells 7 h
postinfection and then reverse transcribed (AMV reverse
transcriptase, Boehringer Mannheim) using a comple-
mentary primer in the 2C gene (nt 4133–4152). The re-
sulting cDNA was amplified by PCR (Taq polymerase and
Taq Extender, Stratagene) using a genomic primer in the
59NC region (nt 162–182). The amplified fragment of 3990
nt was digested by NcoI (nt 477–3813) and then used to
replace the corresponding segment in the plasmid pT7-
Leon. The resulting virus, T7L/P1(L2-2), was isolated
after transfection of IMR-32 cells by the calcium phos-
phate method (Graham and Van der Eb, 1973). A second
virus carrying only four of the seven missense mutations
and two silent mutations, T7L/P1(L2-2/T7L), was isolated
after transfection with a plasmid constructed by replac-
ing the AvrII–XmaI fragment (nt 1249–2766) of pT7L/
P1(L2-2) by the corresponding fragment from pT7-Leon.
All of the other mutant viruses containing one, two, or
three point mutations were constructed by site-directed
mutagenesis and recombination. Briefly, two fragments
of the T7-Leon genome were prepared for site-directed
mutagenesis as follows: the first one was excised di-
rectly from pT7-Leon by SacI (nt 787–1935) and the sec-
ond one was prepared by PCR amplification of pT7-Leon
(Vent polymerase, New England Biolabs) (nt 2663–4558)
followed by digestion with HindIII and EcoRI (nt 2867–
4241). Next, both fragments were subsequently cloned
independently into the multiple cloning site of the vector
M13mp18 (Messing et al., 1977). Site-directed mutagen-
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esis was then performed using the Sculptor in vitro
mutagenesis system (Amersham) and the following
three complementary mutated oligonucleotides: 59-GTT-
GCAACAATCTATCAC-39 (nt 995–978), 59-GTCCCATGAC-
CTTGGTGTG-39 (nt 2983–2965), and 59-ATAAGGGGT-
TCAAGTTG-39 (nt 3353–3337) in which mutations 986
C 3 A, 2973 T 3 C, and 3344 C 3 T respectively, are
underlined. Following mutagenesis, the cloned frag-
ments were sequenced to verify the presence of the
desired mutations and the absence of additional muta-
tions. The mutated fragments were then excised by ei-
ther SacI (nt 787–1935) or by BstEII and BssHII (nt 2881–
3295 and nt 3295–3916) and cloned back into pT7-Leon,
either singly or in various combinations (Fig. 1). All of the
corresponding mutant viruses were obtained by trans-
fection of IMR-32 cells. The entire P1 capsid-encoding
region of the viral genome was sequenced for the per-
sistent mutant T7L12L131N290 while only the region in-
cluding each of the introduced mutations was se-
quenced for all of the other point mutants.
RNA sequencing
Viruses were amplified by a single passage in IMR-32
cells when necessary. Either purified PV RNA or total
cytoplasmic RNA from PV-infected IMR-32 cells was se-
quenced with avian myeloblastosis virus reverse tran-
scriptase (Promega) as described (Christodoulou et al.,
1989).
Establishment of persistent infection in HEp-2c cell
cultures
Confluent HEp-2c cells were infected at an m.o.i. of
about 1024 ID50/cell, in order to determine the phenotype
of persistence of the PV mutants in comparison to the
negative control, PV3 Leon. Infected cells were grown at
37°C, in DMEM–2% FCS for the first week and then in
DMEM-10% NCS for a minimum of 7 weeks, changing
the medium once per week. Flasks containing a large
number of living cells were trypsin treated and surviving
cells were divided once per week.
Phenotypic analysis of parental and mutant viruses
The difference in titer (log10 ID50/ml) on IMR-32 versus
HEp-2c cells was determined in 96-well plates, using the
following endpoint micromethod: cells were infected im-
mediately after trypsinization with 10-fold dilutions of
virus and incubated in DMEM–2% FCS at 37°C. Cyto-
pathic effects were evaluated under the microscope after
7 days. In order to determine the size of plaques on
HEp-2c cells, subconfluent cell monolayers were in-
fected as previously described (Pelletier et al., 1991).
Transcription in vitro
Thirty micrograms of pT7-Leon (and related construc-
tions containing mutations as indicated in Fig. 1) were
first linearized with the restriction enzyme SalI which
cuts after the poly(A) tail of the PV genome. The linear
DNA was then transcribed in vitro with T7 RNA polymer-
ase (Promega) following the manufacturer’s directions.
RNA transfection and single-cycle growth
experiments
In the RNA transfection experiments, HEp-2c cell
monolayers in six-well plates were transfected with RNA
transcripts using the DEAE–dextran method as previ-
ously described (van der Werf et al., 1986). Briefly, 1.2 mg
of RNA transcripts was incubated 30 min on ice with 60
mg of DEAE–dextran in N-2-hydroxyethylpiperazine-N9-2-
ethanesulfonic acid (HEPES)-buffered saline. Cells were
washed twice with serum-free DMEM and then incu-
bated 30 min at room temperature with the transcripts in
500 ml of the same medium. One milliliter of serum-free
DMEM was added, and the cells were incubated 1 h at
37°C. The medium was then replaced by 2 ml of
DMEM–2% FCS and the cells were incubated at 37°C for
4, 6, and 8 h. For the single-cycle growth experiments,
confluent HEp-2c cell monolayers were infected at a
m.o.i. of 10 ID50/cell and incubated for 2, 4, 6, 8, and 24 h
at 37°C. For both types of experiments, the intracellular
and extracellular virus was recovered by freezing and
thawing, clarified, and titered on IMR-32 cells.
Preparation of radiolabeled virions
Viruses were labeled with [35S]methionine (ICN; 1400
Ci/mmol) and purified in a cesium chloride density gra-
dient by isopycnic centrifugation as previously described
(Blondel et al., 1983; Pelletier et al., 1991).
Virus adsorption onto HEp-2c cells
Virus adsorption was studied on cells in suspension
on ice as previously described (Calvez et al., 1995).
Radiolabeled viruses were added to 1.5 3 106 cells at a
m.o.i. of 70 ID50/cell in 150 ml of ice-cold DMEM–2% FCS.
Infected cells were then agitated on ice for 0 min, 30 min,
1 h, 1.5 h, 2 h, 2.5 h, 3 h, and 3.5 h. Unattached virus was
removed by two washes with ice-cold DMEM–2% FCS,
and the cell-associated radioactivity was counted and
expressed as a percentage of the radioactivity present in
the inoculum.
Particle elution from HEp-2 cells at 37°C
HEp-2c cells were trypsinized and washed with ice-
cold DMEM–2% FCS. Radiolabeled viruses were then
added to 2.25 3 106 cells at a m.o.i. of 90 ID50/cell in 1.2
ml of the same medium. Infected cells were agitated on
ice for 2.5 h and then unattached virus was removed by
two washes with ice-cold DMEM–2% FCS. Cells were
resuspended in 1.6 ml of the same medium and then
divided into 200-ml aliquots. Three milliliters of
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DMEM–2% FCS preheated to 37°C was added and the
cells were shaken at 37°C for 0 min, 30 min, 1 h, 1.5 h,
2 h, and 2.5 h. Cells were washed once again and the
cell-associated radioactivity was then counted and ex-
pressed as a percentage of the radioactivity present
prior to the 37°C incubation period.
Analysis of the early virus–receptor interactions
Sucrose gradient centrifugation was used to analyze
the early steps of the virus cycle, according to a slightly
modified version of the protocol described by Couderc et
al. (1996). Briefly, HEp-2c cells were trysinized and
washed with ice-cold DMEM–2% FCS. Radiolabeled vi-
ruses were then added to 107 cells, on ice, at a m.o.i. of
about 200 ID50/cell in 2 ml of the same medium. For the
initial experiments, infected cells were incubated 2.5 h
on ice in order to synchronize the infection and then
agitated at 37°C for 0, 15, 30, 60, or 90 min. Cells were
then washed twice with ice-cold DMEM–2% FCS, and
once with ice-cold phosphate-buffered saline (PBS). Cell
pellets were resuspended in 450 ml of 140 mM NaCl, 50
mM Tris, pH 8.0, and then were lysed for 20 min on ice
by the addition of 50 ml of 140 mM NaCl, 50 mM Tris, pH
8.0, 10% NP-40, and 1% SDS. Lysed cells were pelleted
and then the cell lysate was layered onto 15 to 30% (w/v)
sucrose gradients prepared in PBS, which were centri-
fuged in a Kontron TST41.14 rotor for 2 h at 40000 rpm at
4°C. Gradients were fractionated and the radioactivity
per fraction was counted. For the later experiments,
infected cells were either agitated 0, 15, 45, or 90 min on
ice or agitated 0, 45, or 90 min directly at 37°C, at which
point cells were pelleted, and, if desired, 450 ml of su-
pernatant was removed. All subsequent steps were car-
ried out as described above for the first experiments,
except that the supernatants were also lysed and ana-
lyzed by sucrose gradient centrifugation.
160S virions and 80S particles purified by CsCl cen-
trifugation were used as sedimentation markers in par-
allel gradients. The sedimentation coefficient corre-
sponding to the novel peak shown in Figs. 4–6 was
estimated to be 147 6 3S by linear interpolation based
on the positions of the fractions containing the 160S and
135S particles. This value represents the average calcu-
lated from six different experiments 61 standard devia-
tion. The specific activity of the lytic T7-Leon strain was
2.6 3 1024 cpm/ID50 as opposed to 7.3 3 10
25 cpm/ID50
for the persistent mutant T7L12L131N290.
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